These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 23928649)
21. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants. Demirel B; İmamoglu E; Gursoy T; Demirel U; Topçuoglu S; Karatekin G; Ovali F J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440 [TBL] [Abstract][Full Text] [Related]
22. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317 [TBL] [Abstract][Full Text] [Related]
23. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients. Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323 [TBL] [Abstract][Full Text] [Related]
24. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667 [TBL] [Abstract][Full Text] [Related]
25. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy. Covajes C; Scolletta S; Penaccini L; Ocampos-Martinez E; Abdelhadii A; Beumier M; Jacobs F; de Backer D; Vincent JL; Taccone FS Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601 [TBL] [Abstract][Full Text] [Related]
26. Optimising vancomycin doses in continuous infusion for septic patients. Taccone FS; Jacobs F Int J Antimicrob Agents; 2011 Apr; 37(4):385; author reply 385-6. PubMed ID: 21316927 [No Abstract] [Full Text] [Related]
27. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion. Waineo MF; Kuhn TC; Brown DL J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426 [TBL] [Abstract][Full Text] [Related]
28. Continuous Infusion Vancomycin Through the Addition of Vancomycin to the Continuous Renal Replacement Therapy Solution in the PICU: A Case Series. Cies JJ; Moore WS; Conley SB; Muneeruddin S; Parker J; Shea P; Chopra A Pediatr Crit Care Med; 2016 Apr; 17(4):e138-45. PubMed ID: 26890194 [TBL] [Abstract][Full Text] [Related]
29. Neonatal vancomycin trough level audit using British National Formulary for Children dosing. Petrie K; O'Brien C; Bhushan S; Tonna A Arch Dis Child Fetal Neonatal Ed; 2015 May; 100(3):F278-9. PubMed ID: 25519438 [No Abstract] [Full Text] [Related]
30. Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis. Hao JJ; Chen H; Zhou JX Int J Antimicrob Agents; 2016 Jan; 47(1):28-35. PubMed ID: 26655032 [TBL] [Abstract][Full Text] [Related]
31. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Kitzis MD; Goldstein FW Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555 [TBL] [Abstract][Full Text] [Related]
32. Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion. Hanrahan T; Whitehouse T; Lipman J; Roberts JA Int J Antimicrob Agents; 2015 Sep; 46(3):249-53. PubMed ID: 26141230 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic drug monitoring in neonates. Pauwels S; Allegaert K Arch Dis Child; 2016 Apr; 101(4):377-81. PubMed ID: 26803050 [TBL] [Abstract][Full Text] [Related]
34. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection. Di Filippo A; De Gaudio AR; Novelli A; Paternostro E; Pelagatti C; Livi P; Novelli GP Chemotherapy; 1998; 44(1):63-8. PubMed ID: 9444411 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of a dosing regimen for continuous vancomycin infusion in critically ill patients: an observational study in intensive care unit patients. Saugel B; Gramm C; Wagner JY; Messer M; Lahmer T; Meidert AS; Schmid RM; Huber W J Crit Care; 2014 Jun; 29(3):351-5. PubMed ID: 24456810 [TBL] [Abstract][Full Text] [Related]
36. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target? Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193 [TBL] [Abstract][Full Text] [Related]
37. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus. Duszynska W; Taccone FS; Hurkacz M; Wiela-Hojenska A; Kübler A Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702 [TBL] [Abstract][Full Text] [Related]
38. Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients. Fung L Ann Pharmacother; 2012 Oct; 46(10):e26. PubMed ID: 23032658 [TBL] [Abstract][Full Text] [Related]
39. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion. Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966 [TBL] [Abstract][Full Text] [Related]
40. Vancomycin prescription in neonates and young infants: toward a simplified dosage. Oudin C; Vialet R; Boulamery A; Martin C; Simon N Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]